Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that its cannabis breeding and in-vitro propagation business segment (a joint venture with Rahan Meristem and CEPG, the “JV”) is vetting top candidates to fulfill the lead scientist role for its state-of-the-art laboratory in St. John’s, Newfoundland.

This move ushers in a new phase of planning and development for the space, slated to be completed in November of 2018. The objective for the JV is to position the Company as a research leader in genetics, biochemistry and in-vitro technology in the cannabis space. Research and development in St. John’s will help shape the future of cannabis research thought leadership while gaining valuable insight into propagation, cultivation and manufacturing. Additionally, this strategic JV is expected to create valuable IP to be sold worldwide, providing global reach on a scale thus far unrealized in the cannabis ecosystem.

Leveraging Rahan Meristem’s proprietary technology of non-GMO, in-vitro mutagenesis, Future Farm hopes to make significant strides in the medical applications of the plant.

“The future of agro-biotechnology as it relates to the cannabis plant is in its infancy. The top minds in their respective fields will help pave the way for powerful, ethical applications of this historically underutilized resource. Our strict vetting of top-tier geneticists will guide our vision of developing safe and valuable treatments, fulfilling clear and undeniable social imperative,” states Dr. Eli Khayat, biochemist and plant breeder, Vice President of Research and Development for Rahan Meristem.

On behalf of the Board,

Future Farm Technologies Inc.

William Gildea, Chairman & CEO

About Future Farm Technologies Inc.

Future Farm is a Canadian company with holdings throughout North America including California, Massachusetts, Florida, Maine, Puerto Rico and Newfoundland. The Company’s mission is to advance sustainable agriculture through production of wholesale and retail cannabis products, including hemp. As a leader in its field, Future Farm is committed to using only the highest quality processes and products. Towards this goal, the Company acquires or partners with licensed-cannabis operators, and acquires or develops leading technologies in cannabis production, breeding, genetics, and Controlled Environment Agriculture (CEA). Future Farm’s scalable, indoor CEA systems utilize minimal land, water and energy resources. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

For further information, contact:

William Gildea,

Director

(888)387-3761